AURORA: Crestor 10mg Versus Placebo in Subjects With End-stage Renal Disease (ESRD)
Clinical trial NCT00240331 · COMPLETED
Trial details
- NCT number
- NCT00240331
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-01-01
- Primary completion
- 2008-10-01
- Enrollment
- 2776
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.